As a healthcare professional and advocate for evidence-based addiction treatment, I strongly support the petition to amend these regulations governing the prescribing of buprenorphine (Suboxone). The proposed changes would reduce unnecessary barriers to care and better align clinical practice with current scientific understanding of opioid use disorder (OUD). These changes are practical, patient-centered, and supported by leading medical organizations. I urge the Board to adopt them in the interest of saving lives and improving access to timely, individualized care. 

Carrie Grassi, MSN, ANP, CARN-AP